Published online before print December 27, 2004, doi: 10.1161/01.CIR.0000150335.01285.12
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;111:143-149.)
© 2005 American Heart Association, Inc.
Coronary Heart Disease |
Clinical Progression of Incidental, Asymptomatic Lesions Discovered During Culprit Vessel Coronary Intervention
From the University of Pennsylvania, Philadelphia (R.G., R.L.W.); University of Pittsburgh, Pittsburgh, Pa (F.S., H.A.C., K.M.D.); University of Chicago, Chicago, Ill (D.P.F.); Uniformed Services University of the Health Sciences, Bethesda, Md (W.K.L.); and New York University Medical Center, New York, NY (J.S.).
Correspondence to Robert L. Wilensky, MD, 9 Gates Pavilion Cardiology, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104.
Received April 23, 2004; revision received August 27, 2004; accepted September 8, 2004.
Background— With the reduction in restenosis rates by drug-eluting stents, there is new controversy concerning the optimal management of incidental, nontarget lesions identified during percutaneous coronary intervention (PCI). Such lesions have been treated conservatively because of risk of restenosis but now are being considered for PCI to prevent plaque instability. However, the impact of incidental stenoses on future cardiac events remains unknown.
Methods and Results— We performed a retrospective cohort study to determine the rate and features of clinical plaque progression using the National Heart, Lung, and Blood Institute Dynamic Registry of consecutive patients undergoing PCI at multiple centers in 1997 to 1998 and 1999. Of 3747 PCI patients, 216 (5.8%) required additional nontarget lesion PCI for clinical plaque progression at 1 year. Fifty-nine percent presented with new unstable angina, and 9.3% presented with nonfatal myocardial infarction. Patients with multivessel coronary artery disease during original PCI were more likely to require nontarget lesion PCI during follow-up (adjusted odds ratio, 1.72 [95% CI, 1.18 to 2.52] for 2 vessels; adjusted odds ratio, 3.37 [95% CI, 2.32 to 4.89] for 3 vessels). Angiographic review showed that the majority (86.9%) of lesions requiring subsequent PCI were 
60% in severity during original PCI, with the mean lesion stenosis 41.8±20.8% at the time of the initial PCI and 83.9±13.9% during the recurrent event.
Conclusions— Approximately 6% of PCI patients will have clinical plaque progression requiring nontarget lesion PCI by 1 year. Greater coronary artery disease burden confers a significantly higher risk for clinical plaque progression.
Key Words: atherosclerosis • angioplasty • plaque • coronary disease
Related Articles:
Circulation 2005 111: 119.
Circulation 2005 111: 125-126.
This article has been cited by other articles:
 |
|
 |
|
  P. Meimoun, T. Benali, F. Elmkies, S. Sayah, A. Luycx-Bore, L. Doutrelan, Z. Hamdane, J. Boulanger, and C. Tribouilloy Prognostic value of transthoracic coronary flow reserve in medically treated patients with proximal left anterior descending artery stenosis of intermediate severity Eur J Echocardiogr, June 25, 2008; (2008) jen190v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. O. Caymaz and G. Yuksel Fate of Incidental, Asymptomatic Lesions Discovered During Percutaneous Coronary Intervention Angiology, May 1, 2008; 59(2): 193 - 197. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Okura, H. Taguchi, T. Kubo, I. Toda, M. Yoshiyama, J. Yoshikawa, and K. Yoshida Impact of arterial remodelling and plaque rupture on target and non-target lesion revascularisation after stent implantation in patients with acute coronary syndrome: an intravascular ultrasound study Heart, October 1, 2007; 93(10): 1219 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Cheruvu, A. V. Finn, C. Gardner, J. Caplan, J. Goldstein, G. W. Stone, R. Virmani, and J. E. Muller Frequency and Distribution of Thin-Cap Fibroatheroma and Ruptured Plaques in Human Coronary Arteries: A Pathologic Study J. Am. Coll. Cardiol., September 4, 2007; 50(10): 940 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Konig and V. Klauss Virtual histology Heart, August 1, 2007; 93(8): 977 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Spinler and R. L. Wilensky Duration of clopidogrel therapy after placement of drug-eluting intracoronary stent Am. J. Health Syst. Pharm., July 1, 2007; 64(13): 1432 - 1434. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Waxman, F. Ishibashi, and J. E. Muller Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events Circulation, November 28, 2006; 114(22): 2390 - 2411. [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Burke, M. Joner, and R. Virmani IVUS-VH: a predictor of plaque morphology? Eur. Heart J., August 2, 2006; 27(16): 1889 - 1890. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Muller, A. Tawakol, S. Kathiresan, and J. Narula New opportunities for identification and reduction of coronary risk treatment of vulnerable patients, arteries, and plaques. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C2 - C6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sano, M. Kawasaki, Y. Ishihara, M. Okubo, K. Tsuchiya, K. Nishigaki, X. Zhou, S. Minatoguchi, H. Fujita, and H. Fujiwara Assessment of Vulnerable Plaques Causing Acute Coronary Syndrome Using Integrated Backscatter Intravascular Ultrasound J. Am. Coll. Cardiol., February 21, 2006; 47(4): 734 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Klein Are Drug-Eluting Stents the Preferred Treatment for Multivessel Coronary Artery Disease? J. Am. Coll. Cardiol., January 3, 2006; 47(1): 22 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Clinical Progression of Asymptomatic Coronary Lesions Journal Watch Cardiology, April 8, 2005; 2005(408): 7 - 7. [Full Text]
|
|
|
|
|
|
G. W. Vetrovec Optimizing Percutaneous Coronary Intervention Outcomes: The Next Steps Circulation, January 18, 2005; 111(2): 125 - 126. [Full Text] [PDF]
|
|